Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Hussam Jnaid, M.D
Riyadh, Saudi Arabia
Consultant Internal Medicine
King Faisal Specialist Hospital & Research Center
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Riyadh, Saudi Arabia
Consultant Internal Medicine
King Faisal Specialist Hospital & Research Center
USA
Dr. McShane graduated cum laude from Loyola University Chicago with a bachelor of science in biology and earned her medical doctorate from Loyola University Chicago Stritch School of Medicine. Her fellowship in pulmonary and critical care medicine was at the University of Chicago where she remained as faculty after finishing her training. She received the Clinical Service Award for junior faculty by the University of Chicago department of medicine.
In 2020, Dr. McShane accepted an invitation to further focus on NTM lung disease at the University of Texas Health Science Center Tyler (UTHSCT), in Tyler, TX, a nationally renowned acid-fast bacilli laboratory and national referral center for patients with NTM lung disease. At the UTHSCT, Dr. McShane built the center’s first biorepository of sputum and blood samples from bronchiectasis patients with and without NTM lung disease. She served as principal investigator for over twenty clinical trials in bronchiectasis and NTM lung disease, and she received the award for Excellence in Clinical Research from the UTHSCT Department of Medicine.
Dr. McShane served as associate editor for CHEST and the Journal of Clinical Tuberculosis and Other Mycobacteria. In addition, Dr. McShane served as chair of the U.S. National Bronchiectasis Research Registry Consortium from 2023 to 2024.
In August 2025, Dr. McShane moved to the National Heart Lung and Blood Institute at the National Institutes of Health to study the role of genetics in bronchiectasis and NTM lung disease.
Thailand
Dr. Thanthitaweewat is an accomplished interventional pulmonologist and critical care expert based at the Faculty of Medicine at Chulalongkorn University and King Chulalongkorn Memorial Hospital in Bangkok, Thailand. He also serves at the Thai Red Cross Society in Bangkok. He holds certifications from the Thai boards in internal medicine, pulmonary critical care medicine, and interventional pulmonology.
In his current role, Dr. Thanthitaweewat is a clinical instructor in interventional pulmonology, internal medicine, and pulmonary & critical care medicine at these prestigious institutions.
His research focuses on various critical areas, including a randomized controlled trial aimed at reducing extubation failure in post-extubated medical intensive care unit patients through targeted-volume noninvasive ventilation.
Dr. Thanthitaweewat has presented at numerous reputable international congresses, covering a wide range of topics such as techniques in thoracoscopy, thermoplasty, bronchoscopy under ECMO, and the treatment of endobronchial cholangiocarcinoma.
Italy
Paolo Spagnolo is a full Professor of Respiratory Medicine and Director of the Residency Program in Respiratory Medicine at the University of Padua (Italy).
He received his undergraduate training and his MD, and completed his residency in Respiratory Medicine at the University Hospital of Bari (Italy). In 2002, Dr Spagnolo joined the Interstitial Lung Disease Unit of the Royal Brompton Hospital (London), initially as clinical research fellow under the supervision of Professor Ron du Bois and subsequently as Honorary Consultant. In 2008, he completed his PhD at the Imperial College of London under the supervision of Professor Ron du Bois and Professor Ken Welsh, with a thesis on “Genetic predisposition to clinical phenotypes of sarcoidosis”. Between 2008 and 2013, he was research fellow and subsequently Assistant Professor in Respiratory Medicine at the University Hospital of Modena where he joined the Centre for Rare Lung Diseases lead by Professor Luca Richeldi. Since 2015, Dr Spagnolo is a Professor of Respiratory Medicine at the Department of Cardiac, Thoracic, Vascular Sciences and Public Health of the University Hospital of Padua (Italy).
His main research interests include interstitial lung disease and sarcoidosis with emphasis on genetic predisposition, prediction of disease behaviour and clinical trials of novel therapies. Dr Spagnolo is the author or co-author of more than 200 journal articles, review articles and editorials. He is the chair of the Study Group on Sarcoidosis of the European Respiratory Society and the treasurer of the World Association of Sarcoidosis and Other Granulomatous diseases (WASOG).
Riyadh, Saudi Arabia
Assistant Professor of Medicine
College of Medicine
King Saud Bin Abdulaziz University for Health sciences
Consultant Pulmonary Medicine
King Abdulaziz Medical City
Riyadh, Saudi Arabia
Assistant Professor of Medicine
Consultant Pulmonary Medicine
Airways Disease
College of Medicine
King Saud University
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Asthma and Airway Disease
King Fahad Medical City
Dammam, Saudi Arabia
Consultant Pulmonary Medicine
Head, Pulmonary Division
Department of Internal Medicine
Dammam Medical Complex
Riyadh, Saudi Arabia
Assistant Professor of Medicine (Adj.)
College of Medicine, Alfaisal University
Consultant Pulmonary Medicine
Asthma and Sleep Medicine
King Fahad Medical City
Jeddah, Saudi Arabia
Associate Professor of Medicine
Consultant Pulmonary and Sleep Medicine
Department of Medicine
King Abdulaziz University
Riyadh, Saudi Arabia
Professor of Pulmonary Medicine (Adj.)
University of British Columbia, Vancouver, Canada
Pulmonary Medicine
Pulmonary Vascular Unit
Prince Sultan Military Medical City
Hail, Saudi Arabia
Consultant Pulmonary & Internal Medicine
King Salman Specialist Hospital
Hail, Saudi Arabia
Consultant Pulmonary & Internal Medicine
Interstitial Lung Diseases
King Salman Specialist Hospital
Jeddah, Saudi Arabia
Associate Professor of Pediatrics
Division of Pulmonary Medicine
Chairman, Pediatric Department
Faculty of Medicine – Rabigh
King Abdulaziz University
Thailand
Dr. Sriprasart is an experienced interventional pulmonologist based in Thailand, with over ten years of clinical practice. He completed his advanced training in the USA from 2007 to 2014. Currently, he serves as the Director of the Interventional Pulmonology Fellowship program and is a Clinical Instructor in Pulmonary and Critical Care at the Faculty of Medicine, Chulalongkorn University, Bangkok.
In addition, he is the Director of the Bronchoscopy Laboratory at King Chulalongkorn Memorial Hospital, Thai Red Cross Society, in Bangkok. His research interests encompass a range of topics, including asthma management, the PARAPACT study on asthma and allergic rhinitis, bronchial thermoplasty, pleuroscopy for malignant pleural effusion, and cough suppression during endobronchial ultrasound bronchoscopy.
Dr. Sriprasart has authored numerous publications and book chapters on critical subjects such as pulmonary cysticercosis, asthma management, stenting of malignant airways, immunocompromise in severe COVID-19, bronchial thermoplasty, e-smoking, rapid on-site cytologic examination, cryobiopsy, pulmonary sarcoma, angiosarcoma, and more. He also chairs and participates in several esteemed academic and professional committees in Thailand.
Madinah, Saudi Arabia
Assistant Professor of Medicine (Adj.)
University of Texas MD Anderson Cancer Center, Houston, Texas
Consultant Pulmonologist / Interventional Pulmonologist
King Faisal Specialist Hospital and Research Center
Khamis Mushayt, Saudi Arabia
Consultant Pulmonary & Sleep Medicine
Head, Respiratory Unit
Khamis Mushayt General Hospital
Riyadh, Saudi Arabia
Consultant, Pediatric Infectious Diseases
Department of Pediatrics
Deputy Program Director
King Saud Medical City
Riyadh, Saudi Arabia
Consultant Pulmonary & Critical Care Medicine
Director, Adult Critical Care Fellowship Program
King Fahad Medical City
Jeddah, Saudi Arabia
Assistant Professor (Adj.)
College of Medicine, Alfaisal University
King Faisal Specialist Hospital & Research Centre
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Pulmonary Hypertension
Division of Pulmonary Medicine
Department of Medicine
Prince Sultan Military Medical City
Riyadh, Saudi Arabia
Professor of Medicine
Consultant Pulmonary Medicine
Chairman, Saudi Initiative for Asthma
King Abdulaziz Medical City
Riyadh, Saudi Arabia
Professor of Medicine
Consultant Pulmonary Medicine
Department of Medicine
King Faisal Specialist Hospital & Research Center
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Interstitial Lung Disease
Department of Medicine
King Faisal Specialist Hospital & Research Center
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Interventional Pulmonology
Head, Division Pulmonary Medicine
Prince Sultan Military Medical City
Dhahran, Saudi Arabia
Consultant Pulmonologist
Johns Hopkins Aramco Healthcare
Riyadh, Saudi Arabia
Consultant Pulmonary & Sleep Medicine
Head, Asthma and Airway Diseases Unit
Director, Adult Pulmonary Fellowship Program
Division of Pulmonary Medicine
Department of Medicine
Prince Sultan Military Medical City
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Pulmonary Hypertension
Director, Adult Pulmonary Fellowship Program
Director, Internal Medicine Residency Program
King Fahad Medical City
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Pulmonary Rehabilitation
Head, Pulmonary Division
Director, Pulmonary Fellowship Program
Security Forces Hospital Program
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Pulmonary Rehabilitation and Chronic Ventilation
Director, Internal Medicine Residency Training Program
Assistant professor of Medicine (Adj.)
College of Medicine, Alfaisal University
Prince Sultan Military Medical City
Dammam, Saudi Arabia
Assistant Professor of Medicine
Consultant Pulmonary Medicine
Interstitial Lung Disease
Imam Abdulrahman bin Faisal University
Riyadh, Saudi Arabia
Consultant Pulmonary and Sleep Medicine
Division of Pulmonary Medicine
Department of Medicine
King Abdulaziz Medical City
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Interventional Pulmonology
Department of Medicine
King Faisal Specialist Hospital & Research Center
Dhahran, Saudi Arabia
Consultant Pulmonary Medicine
Pulmonary Hypertension
Head, Pulmonary Medicine Unit
King Fahad Medical Military Complex
Abha, Saudi Arabia
Associated Professor of Medicine
Consultant Pulmonary Medicine
Program director of GIM in Aseer Region
Head section Respiratory Unit
Aseer Central Hospital
Riyadh, Saudi Arabia
Consultant Internal Medicine & Infectious Diseases
Prince Sultan Military Medical City
Dhahran, Saudi Arabia
Professor of Medicine (Adj.)
Indiana University School of Medicine
Consultant Internal Medicine and Infectious Diseases
Director of Accreditation and Infection Control
Johns Hopkins Aramco Healthcare
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Pulmonary Hypertension
Lung Health Department
King Faisal Specialist Hospital & Research Center
Al-Ahsa, Saudi Arabia
Consultant Pulmonary and Sleep Medicine
Department of Internal Medicine
King Abdulaziz National Guard Hospital
Riyadh, Saudi Arabia
Professor of Medicine
Consultant Adult Cardiology
Head, CHD Taskforce, SAPH
King Fahad Cardiac Center
King Saud University Medical City
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
Interstitial Lung Disease
King Abdulaziz Medical City
Al-Khobar, Saudi Arabia
Consultant Internal Medicine,
Infectious Disease and Critical Care Medicine
Sulaiman AlHabib Hospital
Alkhobar, Saudi Arabia
Professor of Medicine
Division Head, Pulmonary Medicine
Senior Consultant Intensivist, Pulmonologist
Department of Medicine – KFHU
Al Imam Abdulrahman Bin Faisal University
Kuwait City, Kuwait
Associate Professor of Medicine
College of Medicine, Kuwait University
Consultant Pulmonary Medicine
Head, Respiratory Unit
Al Amiri Hospital
Sharjah, United Arab Emirates
Professor of Surgery
Advisory Group WHO Academy for Lifelong Learning
Director BSS, CCrISP, SSSHP Surgical Simulation RCS England
Co-Editor-in-Chief Annals of Thoracic Medicine
Lead, Clinical Training, Simulation and Medical Education
Chairman, Interprofessional Practice Committee
University of Sharjah
Madinah, Saudi Arabia
Consultant Pulmonary Medicine
Honorary Senior Lecturer, Kings College School of Medicine
Kings College University, London
Director, Department of Research
King Faisal Specialist Hospital & Research Centre
Madinah, Saudi Arabia
Consultant Pulmonary Medicine
Chairman, Outpatient Department
Prince Mohammed bin Abdulaziz Hospital
National Guard Health Affairs
Riyadh, Saudi Arabia
Associate professor (Adj.)
College of Medicine, Alfaisal University
Director, Surgical Lung Transplantation Program
Consultant Thoracic Surgery & Lung Transplantation
King Abdulaziz Medical City
Ministry of National Guard Health Affairs
Riyadh, Saudi Arabia
Consultant Pulmonary & Critical Care Medicine
Lead Lung Transplant Physician
King Abdulaziz Cardiac Center
National Guard Hospital
Muscat, Oman
Consultant Pulmonary Medicine
Department of Medicine
Royal Hospital, Sultanate of Oman
Buraidah, Saudi Arabia
Consultant Pulmonary Medicine
Department of Medicine
King Fahad Specialist Hospital, Ministry of Health
Makkah, Saudi Arabia
Associate Professor of Medicine
Consultant Allergist/Immunologist
Head, Allergy and Immunology Division
Department of Medicine
King Abdullah Medical City
Umm Al-Qura University
Buraidah, Saudi Arabia
Consultant pulmonary medicine
Assistant Hospital Director for Medical Services
Director, Pulmonary Fellowship Program
King Fahd Specialist Hospital
Buraidah, Saudi Arabia
Consultant Pulmonary Medicine
Chairman, Medical Department
Buraidah Central Hospital
Medinah, Saudi Arabia
Consultant Pulmonary & Sleep Medicine
Director, Sleep lab Medicine
Director, pulmonary fellowship Program
Clinical Assistant Professor-Tiabah University
Deputy, Central Ethical Committee
King Fahad Hospital-Madinah
Muscat, Oman
Consultant Pulmonary & Sleep Medicine
Armed Forces Hospital
Italy
Luca Richeldi is Chair of the Division of Pulmonary Medicine and CEMAR (Respiratory Disease Center) at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome. He is currently Professor of Respiratory Medicine at Università Cattolica del Sacro Cuore in Rome (from 1st March 2017).
He is a member and the secretary of the “Infections and Tuberculosis” group of the Cochrane Collaboration. He serves as Associate Editor for the European Respiratory Journal and he is a Member of the Editorial Board of the American Journal of Respiratory and Critical Care Medicine.
He is also a Member of the Clinical Problems Assembly program committee of the American Thoracic Society. He has been part of the panels in charge of the production of the international guidelines on diagnosis and management of idiopathic pulmonary fibrosis and on consensus classification of the idiopathic interstitial pneumonia: these documents have been endorsed by the major international respiratory scientific societies, including the American Thoracic Society and the European Respiratory Society.
Luca Richeldi has published more than 456 articles, reviews, editorials, and he has contributed several chapters in scientific books.
USA
Nicola (Nick) A. Hanania, MD, MS, is the Brown Foundation Professor of Medicine in the Section of Pulmonary and Critical Care Medicine and director of the Airways Clinical Research Center at the Baylor College of Medicine in Houston, Texas. He also serves on the Faculty Senate at Baylor College of Medicine. He is the Chief of Section of Pulmonary, Critical Care and Sleep Medicine at Ben Taub Hospital. He completed his medical training at the University of Jordan in Amman, Jordan, followed by a residency in internal medicine and a fellowship in pulmonary medicine at the University of Toronto, Toronto, Canada. He subsequently completed a fellowship in critical care medicine at Baylor College of Medicine, where he later earned a master’s degree in clinical investigation.
Dr Hanania has received multiple awards, including the ACCP’s Distinguished Scholar in Respiratory Health, Baylor College of Medicine Master Clinician Award, ACCP distinguished CHEST educator (DCE), ACCP Humanitarian Award, Career Investigator Award (K23) from the National Institutes of Health, Fulbright and Jaworski’s Faculty Excellence Award for Teaching and Evaluation, and the Award for Excellence in Teaching from the Department of Medicine at Baylor College of Medicine. He is editor-in-chief of Respiratory Medicine and is associate editor of the journal Lung. He serves on the editorial board of Chest, and COPD (J of COPD Foundation).
Dr Hanania’s research interests focus on the pharmacology and management of asthma and COPD. He has published more than 320 peer-reviewed papers, book chapters, editorials, and reviews on these topics. His research has been funded by NIH, ALA and industry and focuses on clinical trials investigating novel treatments. He is principal investigator for the American Lung Association Airways Clinical Research Center and COPD Gene study at Baylor College of Medicine, as well as principal investigator or co-investigator in several clinical trials in asthma and COPD. Dr Hanania has been invited and has lectured widely at local, regional, national, and international meetings.
Italy
Rosalinda Madonna is Associate Professor of Cardiology at the University of Pisa and Director of the Center for screening, diagnosis and treatment of pulmonary hypertension Azienda Ospedaliera Universitaria Pisana, Italy. She has received her PhD and specialization in Cardiology both in Chieti, Italy. Rosalinda Madonna held a position as research scientist in the Texas Heart Institute, and as adjunct assistant professor in the University of Texas Medical School in Houston, TX. She is past secretary of the European Society of Cardiology (ESC) Council of cardiovascular Basic Science and past Chair of the ESC Working Group Cellular Biology of the Heart.
She has authored 243 research articles/books with H index 48 and 7000 citations. She is a member of Italian Society of Cardiology and European Association Study of Diabetes. She has honored as Young Investigator Award, Italian Society for Hemostasis and Thrombosis Study (SISET) in 2004, and as “Doctor Honoris Causa” of the Semmelweis University, Budapest. Her research focuses on the molecular mechanisms of cardiovascular disease, heart failure and pulmonary arterial hypertension.
Belgium
Renaud Louis is full professor of Respiratory Medicine at Liege University and Head of the department of Respiratory Medicine at CHU Liege Belgium since 2004.
He has been president of the Belgian Thoracic Society 2013-2014 and Secretary of the ERS (European Respiratory Society) group 5.3 “allergy and immunology” in 2000-2003. He currently sits in the steering committee of the SHARP (CRC on severe asthma of the ERS) and has been co-Chair of the ERS task Force on the clinical practice guidelines for the Diagnosis of Asthma in Adults, which was published in the European Respiratory Journal. He is also GINA advocate.
His research interest has always been focused on asthma looking at the relationship between airway inflammation and clinical disease manifestation. He is currently running together with Prof Schleich a busy asthma clinic with more than 300 patients regularly followed and treated with biologics. He is author or co-author of more than 400 papers indexed in PubMed and his current Scopus H and Google Scholar index are 62 and 80 respectively.
He has a long expertise in conducting clinical trials in asthma and COPD for the drug industry since 1996 and is running an operative team of 4 study coordinators and data managers dealing with obstructive airway diseases.
USA
Dr. Sandeep Sahay is a pulmonary and critical care physician specializing in pulmonary vascular diseases. He pursued residency training at Cleveland Clinic hospitals and a fellowship at the University of Texas, Houston, Tx, USA. Driven by a deep passion for pulmonary vascular diseases, he joined the Pulmonary Hypertension (PH) Program at Houston Methodist Hospital, where he now serves as Director. He is also an Associate Professor affiliated with Weill Cornell Medicine.
Dr. Sahay is widely recognized for his contributions to pulmonary hypertension, with a strong focus on improving patient outcomes through research in PH treatment, risk stratification, and ILD-associated PH. As a national leader in the field, he serves as the principal investigator for multiple Phase 2 and 3 clinical trials investigating novel therapies for PH. His expertise has led to invitations to scientific steering committees, national leadership roles, and participation in guideline panels, as well as collaborations with industry and regulatory agencies.
Currently, he chairs the Pulmonary Vascular Diseases Section of the American College of Chest Physicians (CHEST). He was awarded the ACCP CHEST PAH Research Grant in 2017 to study the role of estrogen in portopulmonary hypertension. He has served two consecutive terms on the American Thoracic Society (ATS) Membership Committee and is chairing guideline/consensus statement task forces with the ISHLT, European Respiratory Society, ATS, and CHEST. Additionally, he holds key roles in the American Thoracic Society’s Pulmonary Circulation Assembly, the Pulmonary Hypertension Association’s Scientific Leadership Committee, and the Pulmonary Vascular Research Institute’s innovative drug development initiative.
Over the years, Dr. Sahay has played vital role in program development for annual meetings at CHEST, ISHLT, and PVRI. He has published extensively on pulmonary hypertension and serves as Associate Editor for Pulmonary Circulation, JHLT Open, and Respiratory Medicine. His expertise is further recognized through services on endpoint adjudication committees and Data Safety Monitoring Boards (DSMBs) for NIH-funded studies and multiple clinical trials.
An enthusiastic educator, Dr. Sahay enjoys mentoring faculty, fellows, and medical colleagues worldwide. He has been honored with the Distinguished CHEST Educator Award four consecutive times since 2020. This year in 2025, American Thoracic Society has selected him to be honored as an “Outstanding Clinician”. He finds immense fulfillment in caring for PH patients and believes that he has learned invaluable lessons from them. His passion for advancing care in pulmonary hypertension and interstitial lung disease continues to drive his clinical, research, and educational endeavors.
USA
Dr. Marcos Restrepo, MD, MSc, PhD, FCCP, is a Professor at the Department of Medicine, Division of Pulmonary/Critical Care Medicine, at the University of Texas Health San Antonio (UTHSA). He is an investigator and staff physician at the South Texas Veterans Health Care System, Audie L Murphy Division. He is Medical Director of the Medical Intensive Care Unit at the South Texas Veterans Health Care System, Audie L Murphy Division and the Associate Program Director of the Pulmonary/Critical Care Medicine fellowship program at UTHSA.
Dr. Restrepo completed training and board certifications in internal medicine, infectious disease, pulmonary disease, and critical care medicine. He obtained a Master in Science in Clinical Investigation from UTHSA and a PhD in Medicine from the Universidad de Valencia, Spain.
He has published more than 260 peer review manuscripts and presented at national and international scientific meetings. He is a member of both pneumonia (community acquired and hospital acquired) guidelines sponsored by the American Thoracic Society of America (ATS)/ and Infectious Diseases Society of America (IDSA). He serves as associate editor for European Respiratory Journal (ERJ)and Respirology
Italy
Alberto Papi is Professor of Respiratory Medicine at the University of Ferrara, Italy, and Director of the Respiratory Unit of the Department of CardioThoracic Medicine, S. Anna University Hospital, Ferrara, Italy.
Professor Papi trained in Respiratory Medicine at the University of Parma, and spent 4 years in the UK as a Clinical Research Fellow at the University of Southampton, where he is an Honorary Clinical Lecturer. In 2015, he was made a Fellow of the European Respiratory Society.
He is Member of the GOLD Science Committee.
Professor Papi’s principal field of research is airway inflammation in asthma and COPD, its molecular mechanisms and pharmacological modulation. In his studies, he has taken particular interest in the role of respiratory viral infections in stable/exacerbated obstructive lung diseases, and the underlying molecular and immunological mechanisms. He has coordinated several studies, particularly in asthma and COPD, and he has given presentations at national and international meetings. He has published more than 600 articles in peer-reviewed journals (including NEJM, Lancet, Lancet Respiratory Medicine, AJRCCM, ERJ), and several other publications in non-peer-reviewed journals. H Index 106.
Australia
Dan Chambers is a thoracic transplant physician, interstitial lung disease expert, clinical triallist and Professor of Medicine at The University of Queensland, Brisbane, Australia. He is Chief Medical Officer of Californian biotech Rejuvenation Technologies whose mission is to develop treatments for people suffering from diseases characterised by telomere shortening.
Dan has been named Australia’s most cited researcher in the field of transplantation for each of the past 5 years. He was previously Executive Director of Research at Australia’s largest health service. Dan’s research focusses on the mechanisms, diagnosis and treatments for pulmonary fibrosis, telomere biology disorders, silicosis, and post-transplant complications. He is a global leader in investigator led and commercially sponsored interventional clinical trials in pulmonary fibrosis. He heads one of Australia’s largest pulmonary fibrosis clinics and one of the world’s largest pulmonary fibrosis clinical trial centres. Of 334 global sites, his was the highest recruiter for the recently concluded studies of nerandomilast in IPF and PPF.
He founded and previously chaired the Pulmonary Fibrosis Australasian Clinical Trial Network, in collaboration with Lung Foundation Australia. Dan spearheaded the development of new diagnostic and treatment methods for silicosis leading to his appointment to a federal taskforce to redress the re-emergence of this pneumoconiosis in Australia. He was prominent in advocating for a ban on engineered stone products, enacted by the Australian government in 2024. Dan’s work as Associate Director of the International Heart and Lung Transplant Registry (2018-2022) has impacted on donor and recipient management globally, with specific impacts on size matching, organ preservation and donation after cardiac death.
USA
Dr. Antonio Anzueto is a Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, an affiliated Institution with the University of Texas Health San Antonio and specializes in Pulmonary Medicine/ Critical Care.
He completed His undergraduate studies at Colegio Liceo Javier in 1972. He received his Doctor of Medicine in 1979 at the University of San Carlos, in Guatemala City. In 1989, he completed her internship and residency in internal medical followed by Pulmonary Medicine/ Critical Fellowship at University of Texas, Health, San Antonio.
He is an active member of the American Thoracic Society, American College of Chest Physicians (CHEST), European Respiratory Society, Latin American Thoracic Society (ALAT), Global Obstruction Lung Disease (GOLD). Dr. Anzueto has over 300 publications in other high rated journals Dr. Anzueto have participate as a member of the Executive and Scientific Committee of the World Global COPD (GOLD Initiative); American Thoracic Society (ATS) and European Respiratory Society (ERS), COPD Guidelines committee (2004, 2010); ATS/ERS COPD Exacerbation Guidelines committee (2018); ARDS – ATS/ERS/European Critical Care Society, ARDS Berlin conference (2012); ATS/Infectious Diseases Society of America (IDSA) community acquired pneumonia clinical practice guidelines (CAP) (2005, 2019). His expertise in Pulmonary and Critical Care has been recognized by the ERS in 2015 when he was name “Honorary Fellow of the ERS” and in 2018 by the ATS that also named him “Honorary Fellow”.
Riyadh, Saudi Arabia
Professor & Consultant Pulmonary Medicine
President, Saudi Thoracic Society
Chairman, STS 2025 International Conference
King Saud University Medical City
Riyadh, Saudi Arabia
Professor & Consultant Thoracic Surgeon
Deputy Head, Division of Thoracic Surgery
Department of Surgery
Associate Director, Thoracic Surgery Fellowship Program
King Saud University Medical City
Sharjah, United Arab Emirates
Professor & Consultant Pulmonary Medicine
Vice-President, Saudi Thoracic Society
Chairman, Clinical Sciences Department
College of Medicine, University of Sharjah, UAE
Riyadh, Saudi Arabia
Consultant Pulmonary& Critical Care Medicine
King Faisal Specialist Hospital & Research Centre
Riyadh, Saudi Arabia
Professor of Medicine
Consultant Pulmonary & Critical Care Medicine
Almishari Hospital
Riyadh, Saudi Arabia
Assistant Professor of Medicine (Adj.)
College of Medicine, Alfaisal University
Consultant Pulmonary Medicine
Director, Sleep Medicine
Department of Medicine
King Faisal Specialist Hospital & Research Center
Dammam, Saudi Arabia
Consultant Allergist/Immunologist
National Guard Health Affairs
Al Imam Abdulrahman Bin Faisal Hospital
Abu Dhabi, UAE
Consultant Cardiologist & Cardiac Electrophysiology
Cleveland Clinic Abu Dhabi
Riyadh, Saudi Arabia
Consultant Pulmonary Medicine
King Fahad Medical City
Adult Cystic Fibrosis and Bronchiectasis
Riyadh, Saudi Arabia
Associate Professor of Medicine (adj.)
MGH-Institute of Health Professions, Boston, MA, USA
Consultant, Pulmonary & Critical Care Medicine
King Fahad Medical City
Riyadh, Saudi Arabia
Professor & Consultant Pulmonary Medicine
King Abdulaziz Medical City
Ministry of National Guard Health Affairs
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.